11-2570671-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000218.3(KCNQ1):c.521G>C(p.Arg174Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R174C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.521G>C | p.Arg174Pro | missense_variant | 3/16 | ENST00000155840.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.521G>C | p.Arg174Pro | missense_variant | 3/16 | 1 | NM_000218.3 | P1 | |
KCNQ1 | ENST00000335475.6 | c.140G>C | p.Arg47Pro | missense_variant | 3/16 | 1 | |||
KCNQ1 | ENST00000496887.7 | c.260G>C | p.Arg87Pro | missense_variant | 4/16 | 5 | |||
KCNQ1 | ENST00000646564.2 | c.478-12764G>C | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The p.R174P variant (also known as c.521G>C), located in coding exon 3 of the KCNQ1 gene, results from a G to C substitution at nucleotide position 521. The arginine at codon 174 is replaced by proline, an amino acid with dissimilar properties. This variant has been detected in individuals from long QT syndrome (LQTS) cohorts or with QTc intervals consistent with LQTS (Napolitano C et al. JAMA. 2005 Dec;294(23):2975-80; Schwartz PJ et al. Eur Heart J. 2021 12;42:4743-4755; Ambry internal data). Another alteration at the same codon, p.R174H (c.521G>A), has also been reported in association with LQTS (Splawski I et al. Circulation. 2000;102(10):1178-85). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:16414944). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at